Loading organizations...
Loading organizations...
Biopharmaceutical company developing therapies for HIV and cancer.
InnaVirVax has raised $8.8M across 2 funding rounds.
InnaVirVax has raised $8.8M in total across 2 funding rounds.
InnaVirVax has raised $8.8M in total across 2 funding rounds.
InnaVirVax's investors include Fa Di e, G1J Ile-de-France, Catherine Boule, Paris Region Venture Fund, Christian Pradeyrol, Fa Diese, Pradeyrol Développement, CapDecisif 2.
InnaVirVax has raised $8.8M across 2 funding rounds. Most recently, it raised $3.9M Other Equity in July 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 17, 2015 | $3.9M Other Equity | Fa Di e, G1J Ile-de-France, Catherine Boule, Paris Region Venture Fund, Christian Pradeyrol | |
| Feb 14, 2012 | $4.9M Series B | Fa Diese, Paris Region Venture Fund, Pradeyrol Développement | CapDecisif 2, G1J Ile-de-France |